VCNX
VACCINEX, INC.
Key Financials
Operating Income
$-18735000
↑ 18.1%
Net Income
$-18634000
↑ 8.0%
Revenue
$601000
↑ 5.4%
EPS (Diluted)
$-8.88
↑ 79.7%
Total Liabilities
$5.1M
↓ 14.4%
Total Assets
$2.6M
↓ 28.5%
Shareholders' Equity
$7.4M
↑ 127.9%
Cash & Equivalents
$1.1M
↓ 27.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 4/15/2025 | View on SEC |
| NT 10-K | 4/1/2025 | View on SEC |
| 15-12G | 3/27/2025 | View on SEC |
| EFFECT | 3/25/2025 | View on SEC |
| EFFECT | 3/25/2025 | View on SEC |
| EFFECT | 3/25/2025 | View on SEC |
| EFFECT | 3/25/2025 | View on SEC |
| EFFECT | 3/25/2025 | View on SEC |
| EFFECT | 3/25/2025 | View on SEC |
| EFFECT | 3/25/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VCNX |
| Company Name | VACCINEX, INC. |
| CIK | 1205922 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 585-271-2700 |